Mistras Group (MG) is Trading Higher on Unusual Volume for January 07

Equities Staff |

Mistras Group (MG) experienced unusually high volume on Jan. 07, as the stock gained 15.6% to a closing price of $21.56. The stock saw 341,184 shares trade hands over the course of the day on 2,760 trades. Given that the stock’s average daily volume over the last month has been 111,331 shares a day, this represents a pretty substantial spike over the norm.

Mistras Group has a P/B ratio of 2.47. It also has a P/E ratio of 26.3. The stock has traded between $22.76 and $12.65 over the last 52-weeks, its 50-day SMA is now $20.01, and its 200-day SMA $18.01.

Mistras Group Inc provides technology-enabled asset protection solutions used to evaluate the structural integrity of critical energy, industrial and public infrastructure.

Headquartered in Princeton Junction, NJ, Mistras Group has 5,700 employees and is currently under the leadership of CEO Sotirios J. Vahaviolos.

For a complete fundamental analysis analysis of Mistras Group, check out Equities.com’s Stock Valuation Analysis report for MG. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

THE IMPORTANCE OF THE RUSSELL 3000

The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.